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Cholera in Haiti: please 
do not forget zinc
We commend Louise Ivers and 
colleagues (Dec 18, p 2048)
1 for 
their thoughts around advocating 
for  complementary public health 
inter  ventions that could slow the 
cholera epidemic in Haiti. We are also 
particularly grateful to Partners In 
Health for the synergistic, helpful, and 
timely support provided to our medical 
action during the onset of the outbreak 
in the Artibonite region.
Ivers and colleagues highlight the 
enormous potential beneﬁ  ts (shorter 
duration of illness, decreased volume 
of diarrhoea, and decreased duration 
of pathogen shedding) associated 
with the proper use of antibiotics.
1 We 
concur, but would like to suggest the 
further need to add the systematic 
use of zinc for all paediatric patients 
(those younger than 15 years). Supple-
mentation with zinc in children with 
cholera has been shown to present an 
additional beneﬁ  t over  antimicrobial 
treatment by reducing the duration 
of diarrhoea and overall stool output.
2 
This eﬀ  ect can contribute substantially 
to decreased severity and a reduced 
overall burden of the disease. The 
US Centers for Disease Control and 
Prevention support the use of zinc for 
the paediatric population.
3
Moreover, zinc has been proven to 
be eﬀ   ective in enhancing the T-cell 
and B-cell-driven sero  conversion to 
vibriocidal antibodies in children given 
the oral inactivated cholera vaccine.
4,5 
This aspect is particularly crucial if we 
want to improve vaccine eﬀ  ectiveness 
and achieve, in the years to come, a 
meaningful preventive protection rate, 
aimed at saving thousands of lives.
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We fully agree with the suggestion 
by Rossi and colleagues to include zinc 
supplementation as an integral part 
of the treatment for cholera patients, 
especially children. Zinc supple  ments 
have been shown to reduce the severity 
and duration of diarrhoea, particularly 
in children younger than 5 years, and 
are therefore recom  mended by WHO 
for patients with most diarrhoeal 
diseases, including cholera. In a study in 
Bangladeshi children with cholera, zinc 
reduced vomiting, stool output and 
duration, and hospital stay by 8 h.
1 A 
review of eﬃ   cacy studies on this subject 
found zinc treatment to decrease 
diarrhoea-related mortality by 23%.
2
WHO recommends that 10–20 mg of 
zinc be given every day for 10–14 days 
to all children with diarrhoea; short-
course zinc supplementation reduces 
the incidence of diarrhoea for 
2–3 months.
3 One study indicates that 
5 days of treatment can be as eﬃ   cacious 
as the 10-day treatment in preventing 
diarrhoea in the sub  sequent 3 months 
among children in Bangladesh.
4
We are currently part of a col  labora-
tive academic eﬀ  ort  of  more  than 
40 individuals, including physicians, 
public health profes  sionals, and 
other cholera experts, to synthesise a 
comprehensive strategy of integrated 
prevention and care for Haiti and 
elsewhere.
 Zinc is discussed in this joint 
statement as a crucial component of 
the treatment regimen for cholera. 
To respond to Haiti’s current cholera 
epidemic, we must continue to scale 
up aggressive case ﬁ  nding and treat-
ment eﬀ  orts, including oral rehydration 
therapy, intravenous rehydration, anti-
biotic therapy, and complementary sup-
ple mentation with zinc and vitamin A.
to higher costs of subsequent out-
patient health-care encounters.
4
According to the US Centers for 
Disease Control and Prevention, most 
of these adverse drug events are 
caused by generic drugs,
3 for which no 
incentives exist for the private sector 
to invest in safety and eﬃ   cacy research. 
By designating translational research 
on improved safety and eﬃ   cacy  of 
generic drugs among its key missions, 
the large foreseen public investment in 
the proposed NCATS might be oﬀ  set 
by reduced health-care costs asso-
ciated with adverse drug events and by 
improved eﬃ   cacy. Besides, it will increase 
public trust in the government’s concern 
for personal health and wellbeing.
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Treatment must be linked to 
prevention, including mass vaccination, 
expanded water and sanitation eﬀ  orts, 
and public health messaging that is tied 
to delivery of needed resources (such 
as soap). All of this must be led by the 
Haitian Government to mitigate the 
acute problem of cholera in the short 
term while also strengthening Haiti’s 
public water, sanitation, and health 
systems in the long term.
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Violence against Chinese 
health-care workers
The Lancet has kept a close watch on 
the situation of Chinese health-care 
workers who have been wounded, 
disabled, or even killed by patients 
or their relatives (Feb 19, p 639).
1,2 
We give some possible causes of 
this situation.
First, under the family control policy, 
most Chinese families have only one 
child who becomes the core of the 
family. Thus parents and grandparents 
pay great attention to the health of 
their child. High-income and upper-
middle-income parents particularly 
demand higher-quality health services 
for their children.
Second, out-of-pocket health-care 
payments are high. Starved of funds 
from the government, Chinese hos pitals 
resort to prescribing expensive, and 
often unnecessary, drugs, diagnostics, 
and procedures. These growing out-of-
pocket payments place a heavy burden 
on poor households. Poor workers and 
their dependants (children, spouses, 
and parents) have high expectations 
of the therapeutic eﬃ   cacy  of  such 
expensive treatments.
The situation above stems from 
a common lack of medical under-
standing among the general public. 
Many patients, if a disease progresses, 
will instinctively blame doctors rather 
than taking a reasonable attitude to 
the disease. The Chinese mass media 
have reported many medical disputes 
in recent years, but they have not taken 
the opportunity to spread general 
medical knowledge.
Finally, the low quality of medical 
services in Chinese hospitals is 
universal. Some junior doctors receive 
little regular training, mean  ing that 
their clinical skills are inadequate. 
Additionally, many health-care work ers 
are not medically qualiﬁ  ed at all, and 
currently it is still a great challenge for 
hospitals to verify the qualiﬁ  cations of 
their staﬀ  .
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Medical disputes and tension between 
doctors and patients have increased in 
recent years in China, and doctors have 
become progressively demonised.
1 
On Jan 31, 2011, 2 days before the 
Lunar New Year in China, six surgeons 
in Xinhua Hospital, Shanghai, were 
stabbed by about 20 relatives of a 
patient, who had undergone aortic 
valve replacement and died of 
mediastinitis 47 days after surgey.
A doctor posted a condemnation 
of this vicious crime on the Tianya 
Forum—a popular social media website 
in China. The author suggested that the 
children of these doctor victims would 
never become doctors themselves in 
China because of the escalating violence 
meted out by patients in recent years. 
The topic received more than 90  000 
clicks and nearly 2000 replies within 
2 weeks, and was reposted on hundreds 
of websites and personal blogs.
China has about 20% of the world’s 
population, yet its national health 
expenditure is only 2% of the total 
world expenditure on health.
2 Although 
China’s gross domestic product (GDP) 
has become one of the world’s largest, 
the total expenditure on health is only 
4·3% of GDP, only 44·7% of which is 
govern ment  expenditure.
3 Insuﬃ   cient 
in  vest  ment in public health has 
become a bottleneck in the develop-
ment of Chinese society. Improving 
the ﬁ  nancial input into public health 
and rebuilding a harmonious doctor–
patient relationship are vital for China’s 
health-system reform.
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Joined-up thinking in 
reduction of 
cardiovascular risk
Your Editorial highlighting an expected 
epidemic of premature cardiovascular 
mortality (Feb 12, p 527)
1 makes for 
interesting and rather frightening 
reading for any frontline clinician 
already labouring under this seemingly 
insurmountable burden.
But surely extraordinary circum-
stances call for extraordinary 
For the Tianya Forum see http://
www.tianya.cn/ 